Aleksandar Sekulic named director of dermatology and translational research at City of Hope Phoenix

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Aleksandar Sekulic was named director of dermatology and director of translational research at City of Hope Cancer Center Phoenix. Sekulic was also hired as a professor in the Integrated Cancer Genomics Division at Translational Genomics Research Institute, also called TGen.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents


The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.